Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kybella for submental fat reduction (REFINE-1)
NCT01546142Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Mar 2012
- Primary completion
- May 2013
- Countries
- 2
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fullness, sponsored by Kythera Biopharmaceuticals. Started Mar 2012; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fullness
Beyond the preview
Go deeper on NCT01546142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546142.